Cardinal Health, Inc.
CAH Healthcare Medical Distribution
Cardinal Health, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $254.2 billion, up 14.2% from fiscal 2025. In the quarter to June 2026, revenue grew 5.84%, EPS grew 68.3%, free cash flow grew 10.9% and total debt rose 4.21%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years.
Follow CAH
Cardinal Health, Inc. (CAH) Return on assets
Cardinal Health, Inc.'s return on assets over the twelve months to 30 June 2026 was 3.10%. Over the past ten years it has ranged from −9.04% (fiscal 2020) to 4.44% (fiscal 2016); the current reading is higher than 58% of that period. That is above the Medical Distribution industry median of 0.00% and above the Healthcare sector median of −30.9%.
Return on assets, annual
Embed this chart
Annual newest first
| Period | Return on assets | Change (points) |
|---|---|---|
| FY2026 | 3.10% | (0.08) |
| FY2025 | 3.18% | 1.25 |
| FY2024 | 1.93% | 1.17 |
| FY2023 | 0.76% | 2.88 |
| FY2022 | −2.12% | (3.55) |
| FY2021 | 1.43% | 10.47 |
| FY2020 | −9.04% | (12.41) |
| FY2019 | 3.37% | 2.73 |
| FY2018 | 0.64% | (2.83) |
| FY2017 | 3.47% | (0.97) |
Against its own ten years
Return on assets against peers
| Company | Return on assets |
|---|---|
| MCK McKesson Corporation compare | 5.41% |
| HSIC Henry Schein, Inc. compare | 3.62% |
| COR Cencora, Inc. compare | 3.33% |
| CAH Cardinal Health, Inc. | 3.10% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| HKPD Cellyan Biotechnology Co., Ltd compare | 0.00% |
| ACH Accendra Health, Inc. compare | −9.65% |
| COSM Cosmos Health Inc. compare | −39.6% |
| FOCL FocalTherics compare | −50.3% |
| Medical Distribution industry median | 0.00% |
| Healthcare sector median | −30.9% |
| Market median | 0.00% |
What Return on assets is
ROA tells an investor how much profit a company earns for shareholders from the assets it uses to run its business.
Annual: Net Income Allotted to Shareholders ÷ Average Assets; TTM: Net Income Allotted to Shareholders ÷ Average Assets (latest quarter)
More on CAH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement